Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps

To date, there has been no reliable test to identify unfavorable course of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), especially in aspirin intolerant patients. The research aimed to analyze the expression of transcript variants of <i>PTGS1</i> and <i>PTGS2</i> genes...

Full description

Bibliographic Details
Main Authors: Wioletta Pietruszewska, Wojciech Fendler, Marta Podwysocka, Adam J. Białas, Piotr Kuna, Izabela Kupryś-Lipińska, Maciej Borowiec
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/1/135
id doaj-071925d6d59246a281e749bab17cc047
record_format Article
spelling doaj-071925d6d59246a281e749bab17cc0472021-01-17T00:03:24ZengMDPI AGDiagnostics2075-44182021-01-011113513510.3390/diagnostics11010135Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal PolypsWioletta Pietruszewska0Wojciech Fendler1Marta Podwysocka2Adam J. Białas3Piotr Kuna4Izabela Kupryś-Lipińska5Maciej Borowiec6Department of Otolaryngology, Head and Neck Oncology, Medical University of Lodz, Lodz 90-419, PolandDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USADepartment of Otolaryngology, Head and Neck Oncology, Medical University of Lodz, Lodz 90-419, PolandDepartment of Pathobiology of Respiratory Diseases, Chair of Internal Medicine, Medical University of Lodz, Lodz 90-419, PolandDepartment of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz 90-419, PolandDepartment of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz 90-419, PolandDepartment of Clinical Genetics, Medical University of Lodz, Lodz 90-419, PolandTo date, there has been no reliable test to identify unfavorable course of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), especially in aspirin intolerant patients. The research aimed to analyze the expression of transcript variants of <i>PTGS1</i> and <i>PTGS2</i> genes in the pathobiology of the disease. The study was performed on 409 adult patients: 206 CRSwNP patients including 44 (21.36%) aspirin intolerant patients and 203 healthy volunteers in the control group. Transcript variants of the <i>PTGS1</i> and <i>PTGS2</i> genes named as follows: COX1.1 for NM_000962, COX1.2 for NM_080591, COX1.3 for NM_001271165.1, COX1.4 for NM_001271368.1, COX1.5 for NM_001271166.1, COX2.1 for NM_000963.3, COX2.2 for AY_151286 and COX2.3 for BQ_722004 were confirmed using direct sequencing and quantified using targeted qPCR. The coexistence of all examined transcript variants in the study and the control group and significant differences between both were found. In aspirin sensitive patients, the levels of COX1.2, COX1.3, COX1.4 and COX1.5 isoforms were higher compared to aspirin-tolerant patients. The severity of symptoms was bigger in patients with higher expressions of variants: COX1.1 (R with dCt = −0.134; <i>p</i> = 0.0490), COX1.3 (R = −0.1429; <i>p</i> = 0.0400) and COX1.5 (Rs = −0.1499; <i>p</i> = 0.032). The expression of COX1.1 (Rs = −0.098; <i>p</i> = 0.049) and COX1.5 (Rs = −0.141; <i>p</i> = 0.043) isoforms increased with polyposis advancement in endoscopy. With the CT extent of sinuses opacification, COX1.1 isoform also significantly increased (Rs = −0.163; <i>p</i> = 0.020). The isoforms COX1.3, COX1.4, COX1.5 and COX2.1 may promote milder CRSwNP course. On the contrary, the variants COX1.1, COX1.2 and COX2.2 may be involved in a more aggressive disease.https://www.mdpi.com/2075-4418/11/1/135chronic rhinosinusitis with nasal polypsCRSwNPcyclooxygenase-1cyclooxygenase-2NSAIDsnon-steroidal anti-inflammatory drugs
collection DOAJ
language English
format Article
sources DOAJ
author Wioletta Pietruszewska
Wojciech Fendler
Marta Podwysocka
Adam J. Białas
Piotr Kuna
Izabela Kupryś-Lipińska
Maciej Borowiec
spellingShingle Wioletta Pietruszewska
Wojciech Fendler
Marta Podwysocka
Adam J. Białas
Piotr Kuna
Izabela Kupryś-Lipińska
Maciej Borowiec
Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
Diagnostics
chronic rhinosinusitis with nasal polyps
CRSwNP
cyclooxygenase-1
cyclooxygenase-2
NSAIDs
non-steroidal anti-inflammatory drugs
author_facet Wioletta Pietruszewska
Wojciech Fendler
Marta Podwysocka
Adam J. Białas
Piotr Kuna
Izabela Kupryś-Lipińska
Maciej Borowiec
author_sort Wioletta Pietruszewska
title Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
title_short Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
title_full Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
title_fullStr Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
title_full_unstemmed Expression of Transcript Variants of <i>PTGS1</i> and <i>PTGS2</i> Genes among Patients with Chronic Rhinosinusitis with Nasal Polyps
title_sort expression of transcript variants of <i>ptgs1</i> and <i>ptgs2</i> genes among patients with chronic rhinosinusitis with nasal polyps
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-01-01
description To date, there has been no reliable test to identify unfavorable course of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), especially in aspirin intolerant patients. The research aimed to analyze the expression of transcript variants of <i>PTGS1</i> and <i>PTGS2</i> genes in the pathobiology of the disease. The study was performed on 409 adult patients: 206 CRSwNP patients including 44 (21.36%) aspirin intolerant patients and 203 healthy volunteers in the control group. Transcript variants of the <i>PTGS1</i> and <i>PTGS2</i> genes named as follows: COX1.1 for NM_000962, COX1.2 for NM_080591, COX1.3 for NM_001271165.1, COX1.4 for NM_001271368.1, COX1.5 for NM_001271166.1, COX2.1 for NM_000963.3, COX2.2 for AY_151286 and COX2.3 for BQ_722004 were confirmed using direct sequencing and quantified using targeted qPCR. The coexistence of all examined transcript variants in the study and the control group and significant differences between both were found. In aspirin sensitive patients, the levels of COX1.2, COX1.3, COX1.4 and COX1.5 isoforms were higher compared to aspirin-tolerant patients. The severity of symptoms was bigger in patients with higher expressions of variants: COX1.1 (R with dCt = −0.134; <i>p</i> = 0.0490), COX1.3 (R = −0.1429; <i>p</i> = 0.0400) and COX1.5 (Rs = −0.1499; <i>p</i> = 0.032). The expression of COX1.1 (Rs = −0.098; <i>p</i> = 0.049) and COX1.5 (Rs = −0.141; <i>p</i> = 0.043) isoforms increased with polyposis advancement in endoscopy. With the CT extent of sinuses opacification, COX1.1 isoform also significantly increased (Rs = −0.163; <i>p</i> = 0.020). The isoforms COX1.3, COX1.4, COX1.5 and COX2.1 may promote milder CRSwNP course. On the contrary, the variants COX1.1, COX1.2 and COX2.2 may be involved in a more aggressive disease.
topic chronic rhinosinusitis with nasal polyps
CRSwNP
cyclooxygenase-1
cyclooxygenase-2
NSAIDs
non-steroidal anti-inflammatory drugs
url https://www.mdpi.com/2075-4418/11/1/135
work_keys_str_mv AT wiolettapietruszewska expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT wojciechfendler expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT martapodwysocka expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT adamjbiałas expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT piotrkuna expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT izabelakupryslipinska expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
AT maciejborowiec expressionoftranscriptvariantsofiptgs1iandiptgs2igenesamongpatientswithchronicrhinosinusitiswithnasalpolyps
_version_ 1724335638176595968